Ascopiave SpA
DUS:AVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ascopiave SpA
DUS:AVA
|
IT |
|
Redcare Pharmacy NV
F:RDC
|
NL |
Wall Street
Price Targets
AVA Price Targets Summary
Ascopiave SpA
According to Wall Street analysts, the average 1-year price target for
AVA
is 3.827 EUR
with a low forecast of 3.622 EUR and a high forecast of 4.288 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVA's stock price target?
Price Target
3.827
EUR
According to Wall Street analysts, the average 1-year price target for
AVA
is 3.827 EUR
with a low forecast of 3.622 EUR and a high forecast of 4.288 EUR.
What is Ascopiave SpA's Revenue forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Ascopiave SpA's revenue is
-10%.
The projected
CAGR
for the next 3 years is
8%.
What is Ascopiave SpA's Operating Income forecast?
Projected CAGR
-4%
For the last 14 years the
compound annual growth rate for
Ascopiave SpA's operating income is
2%.
The projected
CAGR
for the next 3 years is
-4%.
What is Ascopiave SpA's Net Income forecast?
Projected CAGR
-28%
For the last 14 years the
compound annual growth rate for
Ascopiave SpA's net income is
21%.
The projected
CAGR
for the next 2 years is
-28%.
